TIL Therapy in Combination With Checkpoint Inhibitors for Metastatic Ovarian Cancer
Clinical trial NCT03287674 · COMPLETED
Trial details
- NCT number
- NCT03287674
- Sponsor
- Inge Marie Svane
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-09
- Primary completion
- 2020-06-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.